Friday, July 24, 2026

Frontline healthcare personnel at risk from COVID-19 because of age or chronic conditions, study...

"Millions of health workers likely to be exposed to SARS–CoV-2 have medical conditions that increase their risk for poor COVID-19 outcomes."

Why is Monsanto losing lawsuits over roundup?

Agrochemical corporation Monsanto created Roundup in the 1970s to help farmers more effectively kill the weeds that harmed their crops. Today, Roundup...
video

People’s vaccine: Calls grow for equal access to coronavirus vaccine as rich countries hoard...

A growing movement is calling for the development of a people’s vaccine and the suspension of intellectual property rights to expand access.

Trump will not use Defense Production Act to order manufacturing of vital medical equipment

With prices rising, supplies lacking, and healthcare officials working endlessly, the importance of vital medical equipment should not be negotiable.

Climate change is making fish smaller

As ocean temperatures climb, many species of fish – tuna among them – likely will shrink.

Australia becomes first country to approve psychedelics as form of medicine

Australia is reclassifying them as “controlled substances” and making them available for use in managed medical settings.

Major new study shows pesticide risk to honey bees

Scientists are calling for a complete ban on neonics, but will governments listen?

Study links childhood residential proximity to polluted St. Louis creek with increased risk of...

The study's findings examined baby teeth to investigate proximity to the creek and cancer risk.
video

Lancet report: 40% of US COVID deaths were preventable. The country needs universal healthcare...

One of the report’s recommendations is reforming the system to a single-payer model like Medicare for All, which President Joe Biden has so far rejected in favor of bolstering the Affordable Care Act.

‘Is it better than nothing? I suppose’: Sanders disappointed by Dems’ drug pricing plan

"It's a very weak proposal" but "we're dealing with the power of PhRMA over the Congress," he said, taking aim at industry lobbyists.